Atlas Trials

Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects

Clinical trial NCT04587713 · COMPLETED

Trial details

NCT number
NCT04587713
Sponsor
Theravance Biopharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Intestinal DisorderBowel Diseases, Inflammatory
Start date
2020-10-16
Primary completion
2020-12-24
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.